MIRA INFORM REPORT
|
Report No. : |
326144 |
|
Report Date : |
09.06.2015 |
IDENTIFICATION DETAILS
|
Name : |
PHARMAPACK INTERNATIONAL B.V. |
|
|
|
|
Registered Office : |
Oude Vest 4 4811HT Breda |
|
|
|
|
Country : |
Netherlands |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
15.07.1983 |
|
|
|
|
Com. Reg. No.: |
KvK-nummer: 27106543 |
|
|
|
|
Legal Form : |
Private Company |
|
|
|
|
Line of Business : |
|
|
|
|
|
No. of Employee : |
74 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Netherlands |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
NETHERLANDS ECONOMIC OVERVIEW
Netherlands, the sixth-largest economy in the euro-zone, is noted for its important role as a European transportation hub, sizable trade surplus, stable industrial relations, and moderate unemployment and inflation. Industry focuses on food processing, chemicals, petroleum refining, and electrical machinery. A highly mechanized agricultural sector employs only 2% of the labor force but provides large surpluses for food-processing and export. Netherlands, along with 11 of its EU partners, began circulating the euro currency on 1 January 2002. The Dutch financial sector suffered as a result of the global financial crisis, due in part to the high exposure of some Dutch banks to US mortgage-backed securities. In 2008, the government injected billions of dollars of capital into financial institutions to stem the deterioration. To address the economic downturn, the government also sought to stimulate the domestic economy by accelerating infrastructure programs, offering corporate tax breaks for employers to retain workers, and expanding export credits. The stimulus programs and bank bailouts, however, resulted in a government budget deficit of 5.3% of GDP in 2010 that contrasted sharply with a surplus of 0.7% in 2008. The government of Prime Minister Mark RUTTE began implementing austerity measures in early 2011 to reduce the budget deficit, and, in 2013, the government brought the budget deficit below the euro-zone limit of 3% of GDP. Though the Dutch economy remains fragile, a gradual improvement in GDP growth in 2014 helped reduce the deficit further through an increase in government tax revenues. Private consumption remains subdued because of high unemployment, low wage growth, and still-high levels of debt, which together with tax increases, have made households reluctant to spend. Private investment and export growth are susceptible to slower activity in the Netherlands’ European trading partners and geopolitical tensions that constrain international trade.
|
Source
: CIA |
Summary
Company name PHARMAPACK
INTERNATIONAL B.V.
Operative address Oude Vest 4
4811HT Breda
Netherlands
Legal form Besloten
Vennootschap
Registration number KvK-nummer:
27106543
VAT-number 006248214
|
Year |
2013 |
Mutation |
2012 |
Mutation |
2011 |
|
Fixed assets |
20.137.920 |
-3,68 |
20.908.382 |
-11,70 |
23.678.672 |
|
Total receivables |
90.579 |
150,50 |
36.159 |
11.452,40 |
313 |
|
Total equity |
20.109.309 |
-3,53 |
20.844.985 |
-10,42 |
23.269.957 |
|
Short term liabilities |
27.682 |
49,25 |
18.547 |
-94,35 |
328.019 |
|
Working capital |
62.897 |
257,13 |
17.612 |
105,37 |
-327.706 |
|
Quick ratio |
3,27 |
67,69 |
1,95 |
|
0,00 |
Contact
information
|
Company name |
PharmaPack International B.V. |
|
Trade names |
Pharmadis PharmaPack International B.V. |
|
Operative address |
Oude Vest 4 |
|
|
4811HT Breda |
|
|
Netherlands |
|
Correspondence address |
Oude Vest 4 |
|
|
4811HT Breda |
|
|
Netherlands |
|
Telephone number |
0767630539 |
|
Fax number |
0767630541 |
|
Email address |
|
|
Website |
Registration
|
Registration number |
KvK-nummer: 27106543 |
|
Branch number |
000017124344 |
|
VAT-number |
006248214 |
|
Status |
Active |
|
|
|
|
First registration company register |
1983-07-15 |
|
Memorandum |
1983-07-15 |
|
Establishment date |
1983-07-15 |
|
|
|
|
Legal form |
Private Company |
|
Last proposed admendment |
2014-05-16 |
|
|
|
|
Issued placed capital |
EUR 453.781 |
|
Paid up share capital |
EUR 453.781 |
Activities
|
SBI |
Manufacture of other chemical products n.e.c. (2059) |
|
|
Manufacture of pharmaceutical preparations (2120) |
|
|
Packaging (8292) |
|
Exporter |
No |
|
Importer |
No |
|
Goal |
fabricage,verpakking,distributie
van,handel in, in- en verkoop,im- en export van chemische, pharmaceutische en
andere produkten;verkrijgen van opbrengsten of royalties uit vervreemding of
afstaan van recht tot gebruik maken van merken,octrooien,modellen,geheime
procedes of recepten,handelsmerken of soortgelijke zaken, in gebruik geven
van nijverheids-,handels- of wetenschappelijke installaties of verlenen van
technische hulp;beleggen in effecten, schuldvorderingen,verkrijgen,bezitten,
vervreemden,verhuren,verpachten,huren,pachten, beheren, ontwikkelen en
bezwaren van onroerende goederen en rechten op of belangen in onroerende
goederen;deelnemen in,oprichten, financieren en beheren van vennootschappen,
bedrijven en andere ondernemingen,opnemen van gelden en lenen van gelden en
afsluiten van financiële transacties,geven van garanties,het zich verbinden voor verplichtingen
van derden verlenen van diensten op het gebied van handel en
financien,verkrijgen,bezitten,vervreemden van of het op
andere wijze handelen met betrekking tot alle soorten van deelnemingen en
belangen in andere vennootschappen, bedrijven en andere
ondernemingen;uitvoeren van alle handelingen die wenselijk, nodig,
gebruikelijk zijn voor of verwant zijn met vorenstaand doel, daarbij
inbegrepen alle handelingen die betrekking hebben op het bestuur van, de
samenwerking met, deelneming in, de verkrijging van of fusie met andere
ondernemingen of vennootschappen |
Relations
Shareholders Medis
Pharma B.V.
Oude Vest 4
4811HT BREDA
Netherlands
Registration number:
271975890000
Percentage: 100%
Companies on same address Amount: 30
Liability statements Gerann
Holding B.V.
Verrijn Stuartlaan 50
2288EP RIJSWIJK ZH
Netherlands
Registration number: 271615450000
Management
Active management A.M.
Mulders (Adriaan Maurice)
Netherlands
Competence: Fully
authorized
Function: Manager
Starting date: 2011-11-30
Date of birth: 1966-07-22, Horst, NL
Employees
|
Year |
2015 |
2014 |
2012 |
2011 |
2010 |
|
Total |
74 |
74 |
74 |
74 |
74 |
Payments
Description Overeenkomstig conditie
Key
figures
|
Year |
2013 |
2012 |
2011 |
2010 |
2009 |
|
Quick ratio |
3,27 |
1,95 |
0,00 |
0,02 |
0,02 |
|
Current ratio |
3,27 |
1,95 |
0,00 |
0,02 |
0,02 |
|
Working capital/ balance total |
0,00 |
0,00 |
-0,01 |
-0,06 |
-0,06 |
|
Equity / balance total |
0,99 |
1,00 |
0,98 |
0,93 |
0,93 |
|
Equity / Fixed assets |
1,00 |
1,00 |
0,98 |
0,93 |
0,93 |
|
Equity / liabilities |
168,72 |
209,38 |
56,89 |
13,58 |
12,51 |
|
Balance total / liabilities |
169,72 |
210,38 |
57,89 |
14,58 |
13,51 |
|
Working capital |
62.897 |
17.612 |
-327.706 |
-375.241 |
-423.396 |
|
Equity |
20.109.309 |
20.844.985 |
23.269.957 |
6.277.124 |
6.283.892 |
|
Mutation equity |
-3,53 |
-10,42 |
270,71 |
-0,11 |
8,57 |
|
Mutation short term liabilities |
49,25 |
-94,35 |
-13,98 |
-11,78 |
-9,95 |
Summary The 2013
financial result structure is a postive working captial of 62.897 euro, which
is in
agreement with 0 % of the
total assets of the company.
The working capital has
increased with 257.13 % compared to previous year. The ratio, with
respect to the total assets
of the company has however, increased.
The improvement between
2012 and 2013 has mainly been caused by an increase of the
current assets.
The current ratio of the
company in 2013 was 3.27. If the current ratio exeeds 3.0, the
company may not be using
its current assets or its short-term financing facilities efficiently .
The quick ratio in 2013 of
the company was 3.27. A company with a Quick Ratio of more than
1 can currently pay back
its current liabilities.
The 2012 financial result
structure is a postive working captial of 17.612 euro, which is in
agreement with 0 % of the
total assets of the company.
The working capital has
increased with 105.37 % compared to previous year. The ratio, with
respect to the total assets
of the company has however, increased.
The improvement between 2011
and 2012 has mainly been caused by an increase of the
current assets.
The current ratio of the
company in 2012 was 1.95. A company with a current ratio between
1.5 and 3.0 generally
indicates good short-term financial strength.
The quick ratio in 2012 of
the company was 1.95. A company with a Quick Ratio of more than
1 can currently pay back its current liabilities.
Financial
statement
Last
annual account 2013
Remark annual account The financial statements shown in the report
relate to the consolidated financial statements of the group.
Type
of annual account Corporate
Annual
account Geste I
B.V.
Verrijn Stuartlaan 50
2288EP RIJSWIJK ZH
Netherlands
Registration number: 271575870000
Balance
sheet
|
Year |
2013 |
2012 |
2011 |
2010 |
2009 |
|
End date |
2013-12-31 |
2012-12-31 |
2011-12-31 |
2010-12-31 |
2009-12-31 |
|
Tangible fixed assets |
1.442.500 |
1.337.500 |
1.337.500 |
770.566 |
759.567 |
|
Financial fixed assets |
18.695.420 |
19.570.882 |
22.341.172 |
5.962.808 |
6.017.730 |
|
Fixed assets |
20.137.920 |
20.908.382 |
23.678.672 |
6.733.374 |
6.777.297 |
|
Total receivables |
90.579 |
36.159 |
313 |
6.106 |
8.849 |
|
Current assets |
90.579 |
36.159 |
313 |
6.106 |
8.849 |
|
Total assets |
20.228.499 |
20.944.541 |
23.678.985 |
6.739.480 |
6.786.146 |
|
Issued capital |
18.151 |
18.151 |
18.151 |
18.151 |
18.151 |
|
Revaluation reserve |
15.936.171 |
16.546.125 |
15.922.083 |
|
|
|
Other reserves |
4.154.987 |
4.280.709 |
7.329.723 |
6.258.973 |
6.265.741 |
|
Total reserves |
20.091.158 |
20.826.834 |
23.251.806 |
6.258.973 |
6.265.741 |
|
Total equity |
20.109.309 |
20.844.985 |
23.269.957 |
6.277.124 |
6.283.892 |
|
Provisions |
91.508 |
81.009 |
81.009 |
81.009 |
70.009 |
|
Short term liabilities |
27.682 |
18.547 |
328.019 |
381.347 |
432.245 |
|
Total short and long term liabilities |
119.190 |
99.556 |
409.028 |
462.356 |
502.254 |
|
Total liabilities |
20.228.499 |
20.944.541 |
23.678.985 |
6.739.480 |
6.786.146 |
Summary
The total assets of the company decreased
with -3.42 % between 2012 and 2013.
This downturn is mainly retrievable in the
fixed asset decrease of -3.68 %.
The asset reduction results in an equity decrease of -3.53 %. Despite
the decrease, the
indebtness increased with 19.72 %.
In 2013 the assets of the company were 99.55
% composed of fixed assets and 0.45 % by
current assets. The assets are being financed
by an equity of 99.41 %, and total debt of 0.59
%.
The total assets of the company decreased
with -11.55 % between 2011 and 2012.
This downturn is mainly retrievable in the
fixed asset decrease of -11.7 %.
Assets reduction is explained by a Net Worth
decrease of -10.42 %, and an indebtedness
reduction of -75.66 %.
In 2012 the assets of the company were 99.83
% composed of fixed assets and 0.17 % by
current assets. The assets are being financed
by an equity of 99.52 %, and total debt of 0.48 %.
Analysis
Branch
(SBI) Legal activities (82)
Region
Groot Den Haag
In the Netherlands 12043 of the companies are
registered with the SBI code 82
In the region Groot Den Haag 1030 of the
companies are registered with the SBI code 82
In the Netherlands 104 of the bankrupcties are
published within this sector
In the region Groot Den Haag 5 of the
bankruptcies are published within this sector
The risk of this specific sector in the
Netherlands is Low
The risk of this specific sector in the region Groot Den Haag is Low
Publications
Filings
19-05-2015: De jaarrekening
over 2013 is gepubliceerd.
29-07-2014: De jaarrekening over 2012 is
gepubliceerd.
28-03-2014: De jaarrekening over 2011 is gepubliceerd.
16-11-2011: De jaarrekening over 2010 is
gepubliceerd.
07-02-2011: De jaarrekening over 2009 is gepubliceerd.
Functions
20-01-2014: Per 15-01-2014 is bestuurder
Bettina Krausenbaum uit functie getreden.
04-06-2012: Per 01-12-2011 is bestuurder
Bettina Krausenbaum in functie getreden.
04-06-2012: Per 14-05-2012 is bestuurder
Jeffrey Martin Rope uit functie getreden.
02-12-2011: Per 30-11-2011 is bestuurder
Adriaan Maurice Mulders in functie getreden.
02-12-2011: Per 30-11-2011 is bestuurder
Jeffrey Martin Rope in functie getreden.
02-12-2011: Per 30-11-2011 is bestuurder Johanna
Clazina Maria Stevers-van der Laan uit
functie getreden.
02-12-2011: Per 30-11-2011 is bestuurder
27115336 Geste Beheer- en
Exploitatiemaatschappij B.V. uit functie
getreden.
Amendments
19-05-2014: Geplaatst kapitaal gewijzigd in
EUR 453.781,00 Gestort kapitaal gewijzigd in
EUR 453.781,00.
19-05-2014: Per 16-5-2014 statuten gewijzigd.
Per 16-5-2014 naam gewijzigd in:
PharmaPack International B.V..
Company
structure
Relations
9
Actavis
Group hf
Reykjavikurvegi
76-78
220Hafnarfjördur
Pósthólf
Iceland
•
Actavis Dutch Holding B.V.
Oude
Vest 4
4811HT
BREDA
Netherlands
Registration
number: 272903830000
•
Actavis Holding CEE B.V.
Oude
Vest 4
4811HT
BREDA
Netherlands
Registration
number: 272903850000
•
Medis Pharma B.V.
Oude
Vest 4
4811HT
BREDA
Netherlands
Registration
number: 271975890000
•
PharmaPack International B.V.
Oude
Vest 4
4811HT
Breda
Netherlands
Registration
number: 271065430000
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.64.11 |
|
|
1 |
Rs.97.84 |
|
Euro |
1 |
Rs.71.12 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.